Compare Johnson & Johnson (JNJ) vs Sirius XM Holdings Inc (SIRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Sirius XM Holdings Inc — how do they compare? Johnson & Johnson trades at $261.43 (market cap $618.09B), while Sirius XM Holdings Inc trades at $26.71 (market cap $8.87B). The key difference: Johnson & Johnson is far larger — about 69.7× Sirius XM Holdings Inc's market cap, and Sirius XM Holdings Inc pays the higher dividend (4.1%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Sirius XM Holdings Inc for 102 Days on average.
| JNJ | SIRI | |
|---|---|---|
Market Cap | $618.09B | $8.87B |
Volume | 6,050,983 | 4,324,672 |
Sector | Health | Media |
52-Week High | $278.43 | $32.59 |
52-Week Low | $186.00 | $19.92 |
Typical Hold Time | 129 Days | 102 Days |
Enterprise Value | $646.37B | $18.16B |
Dividend Yield | 2.09% | 4.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
Sirius XM (SIRI) trades at $26.51, up 2.16% with mixed technical signals showing neutral momentum. The company demonstrates solid fundamentals with a P/E of 10.57 and P/B of 0.75, though recent earnings show volatility with two misses and one beat in the last four quarters. Strong cash flow generation and a new YouTube partnership provide growth catalysts, while high debt levels and competitive pressures remain concerns.
The stock presents a compelling value opportunity with analyst consensus pointing to 30% upside to the $34.43 price target. However, execution risks in advertising expansion and subscription growth, coupled with $10.31 billion in long-term debt, require careful monitoring. Recent institutional buying and positive management commentary suggest confidence in the company's strategic direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →
